Announcements Trials
Browse Landscape

Phase

Phase 3 1Phase 2 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gynecologic 1Gastrointestinal 1

Conditions

Colorectal Neoplasms 32Colonic Neoplasms 20Rectal Neoplasms 11Carcinoma, Hepatocellular 7Neoplasm Metastasis 5Stomach Neoplasms 2Neoplastic Cells, Circulating 2Neoplasms 2Liver Neoplasms 2Recurrence 1Peritoneal Neoplasms 1Pathologic Complete Response 1Pancreatic Neoplasms 1Oligometastatic Gastric Adenocarcinoma 1Neuroendocrine Tumors 1Neoplasms, Second Primary 1Neoplasm, Residual 1Neoplasm Recurrence, Local 1Margins of Excision 1Locally Advanced Rectal Cancer 1Gastro-enteropancreatic neuroendocrine tumor 1Gallbladder Neoplasms 1Cholangiocarcinoma 1Biliary Tract Neoplasms 1

Interventions

Carboplatin 8Paclitaxel 7Hyperthermic Intraperitoneal Chemotherapy 7Bevacizumab 4liposomal doxorubicin 3Gemcitabine 3Oxaliplatin 2Neoadjuvant Therapy 2relacorilant 1phenoxodiol 1pembrolizumab 1oregovomab 1olaparib 1nintedanib 1lobaplatin 1lanreotide 1epothilone B 1atezolizumab 1Trabectedin 1Topotecan 1Therapeutics 1Surgical Procedures, Operative 1Saline Solution 1Leucovorin 1Letrozole 1Laparotomy 1Laparoscopy 1LAIF 900 1Hypericum extract LI 160 1Glucose 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 3 × Peritoneal Neoplasms × Folfox protocol × Clear all
NCT02231086 2021-09-16

COLOPEC

Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)

Phase 3 Completed
204 enrolled 7 charts
GastrointestinalGynecologic

Peritoneal Neoplasms, Colorectal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡